• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
-
 
Approval Date:  05/06/2011
 
Trade Name:  Plavix
 
Generic or Proper Name (*):  clopidogrel bisulfate
 
Indications Studied:  Reduction of the incidence of thrombosis in children with systemic to pulmonary artery shunts for palliation of cyanotic congenital heart disease
 
Therapeutic Category:  Platelet inhibitor
 
Ages Studied:  neonates - 24 months
 
Study #:  2
 
Study Type:  Efficacy/Safety
 
Study Design:  Single-Blind/Placebo
 
No Patients:  906
 
No Centers:  134
 
No Countries:  31
 
BPCA(B), PREA(P):  B
 
Asian:  133
 
-
-